Filings

5 documents · 25 matches

1. DMII Drugs Made In America Acquisition II Corp. 10-Q 2026-08-14

   Item 1 · Note 1. Description of Organization, Business Operations, and Going Concern

   Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going
   5 matches in this document Show context Copy citation

2. DMII Drugs Made In America Acquisition II Corp. 10-Q 2026-05-14

   Item 1 · Note 1. Description of Organization, Business Operations, and Going Concern

   Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going
   5 matches in this document Show context Copy citation

3. DMII Drugs Made In America Acquisition II Corp. 10-K 2026-04-15

   Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going
   7 matches in this document Show context Copy citation

4. DMII Drugs Made In America Acquisition II Corp. 10-Q 2025-11-18

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties
   4 matches in this document Show context Copy citation

5. DMII Drugs Made In America Acquisition II Corp. 8-K 2025-10-02

   Note 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (cont.)

   going concern. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management plans
   4 matches in this document Show context Copy citation